EN | UA
EN | UA

Help Support

Back

Emerging treatment options for refractory headache

Emerging treatment options for refractory headache Emerging treatment options for refractory headache
Emerging treatment options for refractory headache Emerging treatment options for refractory headache

What's new?

The present review focuses on encouraging the use of safe and effective non-invasive stimulation techniques for treating refractory headache.

 A refractory headache is one that shows a lack of response to usual, recommended treatments, but whether this includes a lack of response to acute, preventative, or both, types of medication is still debated. The importance of the need to identify and manage comorbidities in refractory headache patients cannot be overemphasized. Thus, in chronic migraine (CM), mainly, it is critical to recognize medication overuse as in many patients; this makes the individual’s headaches resistant to treatment. There are few effective treatment options for these, particularly for the latter.


Zagami AS reviewed the recent literature on the management of various refractory headaches, particularly CM, and medication overuse headache. There is no consent on the definitions of refractory CM and chronic cluster headache, although there is substantial agreement on some aspects of these terms. Several studies showed the importance of identifying medication overuse headache. There is yet no agreement on how to stop the medication overuse. Few studies recommend the use of preventative medication together with medication cessation. Latest reviews on neuromodulation have used both non-invasive as well as invasive techniques. As per the recent research, the non-invasive vagal nerve stimulation for CM has not shown positive outcomes; however, the data in chronic cluster headache still give hopes. Similar results were demonstrated by the latest studies on occipital nerve stimulation. In past years, new forms of neuromodulation have emerged, which mainly target the sphenopalatine ganglion in different types of headache. Sphenopalatine ganglion stimulation has shown supportive data for the therapy of chronic cluster headache. Data from the previous and new studies provided additional confirmation on the advantage of deep brain stimulation for refractory chronic cluster headache, although the exact point location is still disputed. A phase 3 trials in CM and cluster headache using CGRP monoclonal antibodies could be regarded as a new and effective treatment for our refractory headache patients.

Source:

Curr Pain Headache Rep. 2018 Mar 19;22(4):23.

Article:

Treatment of the Patient with Refractory Headache

Authors:

Zagami AS

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: